Intelgenx Technologies Corp (IGX:TSX-V) Investor Relations Material

Overview

IntelGenx is a Montreal-based oral drug delivery company that specializes in developing and manufacturing pharmaceutical oral films utilizing its proprietary VersaFilm® technology. The company offers a range of comprehensive pharmaceutical services to its partners, including R&D, analytical method development, clinical monitoring, IP, and regulatory services. IntelGenx's state-of-the-art manufacturing facility supports lab-scale-to-pilot and commercial-scale production, providing full-service capabilities to its clients. IntelGenx is listed on both the TSX-V and OTC-QX exchanges and has a highly skilled team of professionals.

Frequently Asked Questions

What is Intelgenx Technologies Corp's ticker?

Intelgenx Technologies Corp's ticker is IGX

What exchange is Intelgenx Technologies Corp traded on?

The company's shares trade on the TSX-V stock exchange

Where are Intelgenx Technologies Corp's headquarters?

They are based in Saint-Laurent, Quebec

How many employees does Intelgenx Technologies Corp have?

There are 11-50 employees working at Intelgenx Technologies Corp

What is Intelgenx Technologies Corp's website?

It is intelgenx.com

What type of sector is Intelgenx Technologies Corp?

Intelgenx Technologies Corp is in the Healthcare sector

What type of industry is Intelgenx Technologies Corp?

Intelgenx Technologies Corp is in the Biotechnology industry

Who are Intelgenx Technologies Corp's peers and competitors?

The following five companies are Intelgenx Technologies Corp's industry peers:

- Valaris

- Acer Therapeutics Inc.

- VBI Vaccines, Inc.

- BioCardia, Inc.

- Satsuma Pharmaceuticals